Douglas R. Bish

Douglas R. Bish

Auto-generated profile, based on publicly available information

Douglas R. Bish

Culverhouse College of Business, The University of Alabama, Tuscaloosa, Alabama 35487

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2011 in OR Spectrum
Verified
Journal Article
Closed access
PDF file
DBDouglas R. Bish
Douglas R. Bish

6 August 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
NNNgoc T. Nguyen
Ngoc T. Nguyen
HAHrayer Aprahamian
Hrayer Aprahamian
EBEbru K. Bish
Ebru K. Bish
DBDouglas R. Bish
Douglas R. Bish
Pooled testing, in which biological specimens from multiple subjects are combined into a testing pool and tested via a single test, is a common testing method for both surveillance and screening activities. The sensitivity of pooled testing for various pool sizes is an essential input for surveillance and screening optimization, including testing pool design. However, clinical data on test sensitivity values for different pool sizes are limited, and do not provide a functional relationship between test sensitivity and pool size. We develop a novel methodology to accurately compute the sensitivity of pooled testing, while accounting for viral load progression and pooling dilution. We demonstrate our methodology on the nucleic acid amplification testing (NAT) technology for the human immunodeficiency virus (HIV). Our methodology integrates mathematical models of viral load progression and pooling dilution to derive test sensitivity values for various pool sizes. This methodology derives the conditional test sensitivity, conditioned on the number of infected specimens in a pool, and uses the law of total probability, along with higher dimensional integrals, to derive pooled test sensitivity values. We also develop a highly accurate and easy-to-compute approximation function for pooled test sensitivity of the HIV ULTRIO Plus NAT Assay. We calibrate model parameters using published efficacy data for the HIV ULTRIO Plus NAT Assay, and clinical data on viral RNA load progression in HIV-infected patients, and use this methodology to derive and validate the sensitivity of the HIV ULTRIO Plus Assay for various pool sizes. We demonstrate the value of this methodology through optimal testing pool design for HIV prevalence estimation in Sub-Saharan Africa. This case study indicates that the optimal testing pool design is highly efficient, and outperforms a benchmark pool design. The proposed methodology accounts for both viral load progression and pooling dilution, and is computationally tractable. We calibrate this model for the HIV ULTRIO Plus NAT Assay, show that it provides highly accurate sensitivity estimates for various pool sizes, and, thus, yields efficient testing pool design for HIV prevalence estimation. Our model is generic, and can be calibrated for other infections.

24 August 2011 in Annals of Operations Research
Verified
Journal Article
Closed access
PDF file
DBDouglas R. Bish
Douglas R. Bish
EAEsra Agca Aktunc
Esra Agca Aktunc
RGRoger Glick
Roger Glick

8 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
HEHussein El-Hajj
Hussein El-Hajj
HAHrayer Aprahamian
Hrayer Aprahamian
Limited testing capacity for COVID-19 has hampered the pandemic response. Pooling is a testing method wherein samples from specimens (e.g., swabs) from multiple subjects are combined into a pool and screened with a single test. If the pool tests positive, then new samples from the collected specimens are individually tested, while if the pool tests negative, the subjects are classified as negative for the disease. Pooling can substantially expand COVID-19 testing capacity and throughput, without requiring additional resources. We develop a mathematical model to determine the best pool size for different risk groups, based on each group’s estimated COVID-19 prevalence. Our approach takes into consideration the sensitivity and specificity of the test, and a dynamic and uncertain prevalence, and provides a robust pool size for each group. For practical relevance, we also develop a companion COVID-19 pooling design tool (through a spread sheet). To demonstrate the potential value of pooling, we study COVID-19 screening using testing data from Iceland for the period, February-28-2020 to June-14-2020, for subjects stratified into high- and low-risk groups. We implement the robust pooling strategy within a sequential framework, which updates pool sizes each week, for each risk group, based on prior week’s testing data. Robust pooling reduces the number of tests, over individual testing, by 88.5% to 90.2%, and 54.2% to 61.9%, respectively, for the low-risk and high-risk groups (based on test sensitivity values in the range [0.71, 0.98] as reported in the literature). This results in much shorter times, on average, to get the test results compared to individual testing (due to the higher testing throughput), and also allows for expanded screening to cover more individuals. Thus, robust pooling can potentially be a valuable strategy for COVID-19 screening.

16 March 2021 in Naval Research Logistics (NRL)
Verified
Journal Article
Closed access
PDF file
HHHussein El Hajj
Hussein El Hajj
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
HAHrayer Aprahamian
Hrayer Aprahamian

10 April 2018 in IISE Transactions
Verified
Journal Article
Open access
HAHrayer Aprahamian
Hrayer Aprahamian
EBEbru K. Bish
Ebru K. Bish
DBDouglas R. Bish
Douglas R. Bish
Pooled testing is commonly used in public health screening for classifying subjects in a large population as positive or negative for an infectious or genetic disease. Pooling is especially useful when screening for low-prevalence diseases under limited resources. Although pooled testing is used in various contexts (e.g., screening donated blood or for sexually transmitted diseases), a lack of understanding of how an optimal pooling scheme should be designed to maximize classification accuracy under a budget constraint hampers screening efforts. We propose and study an adaptive risk–based pooling scheme that considers important test and population level characteristics often over looked in the literature (e.g., dilution of pooling and heterogeneous subjects). We characterize important structural properties of optimal subject assignment policies (i.e., assignment of subjects, with different risk, to pools) and provide key insights. Our case study, on chlamydia screening, demonstrates the effectiveness of the proposed pooling scheme, with the expected number of false classifications reduced substantially over policies proposed in the literature.